Safety and efficacy of infliximab therapy in active Behcet's uveitis: An open-label trial

Rheumatology International

Volumn 29, Issue 1, 2008, Pages 53-57

  Al Rayes, H ^a   Al Swailem, R ^a   Al Balawi, M ^a   Al Dohayan, N ^a   Al Zaidi, S ^a   Tariq, M ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Antitumor necrosis; Behcet's disease; Factor antibody; Uveitis

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; PREDNISOLONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE FREE INTERVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INFUSION; DRUG INFUSION REACTION; DRUG MONITORING; DRUG SAFETY; FOLLOW UP; HEADACHE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA EDEMA; RETINA VASCULITIS; SIDE EFFECT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; UVEITIS; VASCULITIS; VISUAL ACUITY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME; UVEITIS, ANTERIOR; VISUAL ACUITY;

EID: 53149090156     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0606-8     Document Type: Article

References (23)

1. International Study Group for Behçet's Disease 1990 Criteria for diagnosis of Behcet's disease Lancet 335 1078 1080
2. J Tugal-Tutkun S Onal R Altan-Yaycioglu H Huseyin Altunbas M Urgancioglu 2004 Uveitis in Behcet's disease: an analysis of 880 patients Am J Ophthalmol 138 373 380
3. LS Atmaca F Batioglu 1994 The efficacy of cyclosporine-A in the treatment of Behcet's disease Ophthalmic Surg 25 321 327
4. PC Ozdal S Ortac I Taskintuna E Firat 2002 Long-term therapy with low dose cyclosporine A in ocular Behcet's disease Doc Ophthalmol 105 301 312
5. VG Kaklamani PG Kaklamani 2001 Treatment of Behcet's disease: an update Semin Arthritis Rheum 30 299 312
6. K Hamzaoui M Hamza K Ayed 1990 Production of TNF-alpha and IL-1 in active Behcet's disease J Rheumatol 17 1428 1429
7. LM Santos MC Marcos JM Gallardo Galera 2001 Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis Ophthalmic Res 33 251 255
8. A Gul 2001 Behcet's disease: an update on the pathogenesis Clin Exp Rheumatol 19 Suppl 24 S6 S12
9. SR Maini 2004 Infliximab treatment of rheumatoid arthritis Rheum Dis Clin North Am 30 329 347
10. P Rutgeerts G van Assche S Vermeire 2004 Optimizing anti-TNF treatment in inflammatory bowel disease Gastroenterology 126 1593 1610
11. J Braun J Sieper 2004 Biological therapies in the spondyloarthritides: the current state Rheumatology (Oxford) 43 1072 1084
12. G Haugeberg M Velken V Johnsen 2000 Successful treatment of genital ulcers with infliximab in Behcet's disease Ann Rheum Dis 63 744 745
13. I Tugal-Tutkun A Mudun M Urgancioglu S Kamali E Kasapoglu M Inanc A Gul 2005 Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine and corticosteroids in Behcet's disease: an open-label trial Arthritis Rheum 52 2478 2484
14. AP Andonopoulos N Meimaris D Daoussis 2003 Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease Clin Exp Rheumatol 21 Suppl 30 S57 S58
15. MT Kram LD May S Goodman S Molinas 2003 Behcet's Ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case Dis Colon Rectum 46 118 121
16. PP Sfikakis PH Kaklamanis A Elezoglou 2004 Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet's disease Ann Intern Med 140 404 406
17. S Nakamura S Ohno 2005 Anti-tumor necrosis factor alpha antibody in the treatment of Behcet's disease Int Ophthalmol Clin 45 179 189
18. PP Sfikakis PG Theodossiadis CG Katsiari P Kaklamanis NN Markomichelakis 2001 Effect of infliximab on sight-threatening panuveitis in Behcet's disease Lancet 358 295 296
19. VG Kaklamani PG Kaklamanis 2001 Treatment of Behcet's disease: an update Semin Arthritis Rheum 30 299 312
20. P Carmaschi D Biasi M Lombathi 2006 Anti-TNF therapy in rheumatoid arthritis and autoimmunity Rheum Int 26 209 214
21. E Comby P Tanaff D Mariotte 2006 Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with long term infliximab therapy J Rheum 33 24 30
22. M Louis J Rauch M Armstrong MA Fitzcharles 2003 Induction of autoantibodies during prolonged treatment with infliximab J Rheumatol 30 2557 2562
23. B Weill A Kahan 2004 Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clin Exp Rheumatol 22 756 758